STAT3 and hematologic disorder: As such, STAT3 activation is critically involved in the processes of cancer initiation, progression and maintenance [10, 12-15] and elevated levels of active STAT3 are associated with poor prognosis in a host of hematopoietic and non-hematologic malignancies [10, 12, 13, 15, 18, 21].